Production and characterization of guinea pig IL-5 in baculovirus- infected insect cells

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 270, Issue 6 14-6, 1996, Pages

  Mansour, Mahmoud ^b   Karmilowicz, Michael ^b   Hawrylik, Steven J ^b   Nalcerio, Barbara ^b   Angilly, Jane ^b   Conklyn, Maryrose J ^b   Lilly, Craig M ^b   Drazen, Jeffrey M ^b   Lee, S E ^b   Auperin, David D ^b   De Wet, Jeffrey R ^b   Cohan, Victoria L ^b   Showell, Henry J ^b   Danley, Dennis E ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^b NONE

Author keywords

asthma; cytokine; eosinophils

Indexed keywords

INTERLEUKIN 5;

ANIMAL CELL; ARTICLE; ASTHMA; BACULOVIRUS; GENE AMPLIFICATION; GUINEA PIG; INSECT; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN PURIFICATION;

EID: 0004483821     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.1996.270.6.l1002     Document Type: Article

References (25)

1. Aviv, H., and P. Leder. Purification of biologically active globin messenger RNA by oligothymidylic acid-cellulose. Proc. Natl. Acad. Sci. USA 69: 1408-1412, 1972.
2. Azuma, C., T. Tanabe, M. Konishi, T. Kinashi, T. Noma, F. Matsuda, Y. Yaoita, K. Takatsu, L. Hammarstroem, C. I. E. Smith, E. Severinson, and T. Honjo. Cloning of human cDNA for human T-cell replacing factor (IL-5) and comparison with the murine homolog. Nucleic Acids Res. 14: 9149-9158, 1986.
3. Bischoff, S. C., T. Brunner, A. L. DeWeck, and C. A. Dahinden. IL-5 modifies histamine and leucotriene generation by human basophils in response to diverse agonists. J. Exp. Med. 172: 1577-1582, 1990.
4. Burand, J. P., M. D. Summers, and G. E. Smith. Transfection with baculovirus DNA. Virology 101: 286-290, 1980.
5. Catstens, E. B., T. T. Sian, and W. Doerfler. Infectious DNA from Autographa califirnica nuclear polyhedrosis virus. Virology 101: 311-314, 1980.
6. Chomczynski, P., and N. Sacchi. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162: 156-159, 1987.
7. Durham, S. R., and A. B. Kay. Eosinophils, bronchial hyperreactivity and late-phase asthmatic reactions. Clin. Allergy 15: 411-418, 1985.
8. Elbon, C. L., D. B. Jacoby, and A. D. Fryer. Pretreatment with an antibody to interleukin-5 prevents loss of pulmonary M2 muscarinic receptor function in antigen-challenged guinea pigs. Am. J. Respir. Cell Mol. Biol. 12: 320-328, 1995.
9. Ingley, E., R. Cutler, M. C. Fung, C. Sanderson, and I. Young. Production and purification of recombinant human IL-5 from yeast and baculovirus expression systems. Eur. J. Biochem. 196: 623-629, 1991.
10. Jarvis, D. L., and M. D. Summers. Baculovirus expression vectors. In: Recombinant DNA Vaccines, Rationale and Strategy, edited by R. Isaacson. New York: Dekker, 1992, p. 265-290.
11. Kinashi, T., N. Harada, E. Severinson, T. Tanabe, P. Sideras, M. Konishi, C. Azuma, A. Tominaga, S. Bergstedt-Lindqvist, M. Takahashi, F. Matsuda, Y. Yaoita, K. Takatsu, and T. Honjo. Cloning of cDNA encoding T-cell replacing factor and identity with B-cell growth factor II. Nature Lond. 324: 70-73, 1986.
12. Kodama, S., M. Tsujimoto, N. Tsuruoka, T. Sugo, T. Endo, and A. Kobata. Role of sugar chains in the in vitro activity of recombinant human IL-5. Eur. J. Biochem. 211: 903-908, 1993.
13. 4. Nature Lond. 227: 6780-6785, 1970.
14. Maria-Christina, S., and G. J. Gleich. The role of eosinophils in the pathogenesis of asthma. Curr. Opin. Immunol. 6: 860-864, 1994.
15. Matsuura, Y., R. D. Posee, H. A. Overton, and D. H. L. Bishop. Baculovirus expression vectors: the requirements for high, level expression of proteins, including glycoproteins. J. Gen. Virol 68: 1233-1250, 1987.
16. Mauser, P. J., A. Pitman, A. Witt, X. Fernandez, J. Zurcher, T. Kung, H. Jones, A. S. Watnick, R. W. Egan, W. Kreutner, and G. K. Adams. Inhibitory effect of TRFK-J anti-IL-5 antibody in a guinea pig model of asthma. Am. Rev. Respir. Dis. 148: 1623-1627, 1993.
17. Minamitake, Y., S. Kodama, T. Katayama, H. Adachi, S. Tanaka, and M. J. Tsujimoto. Structure of recombinant human IL-5 produced by Chinese hamster cells. J. Biochem. 107: 292-297, 1990.
18. Proudfoot, A. E. I., J. G. Davies, G. Turcatti, and P. T. Wingfield. Human IL-5 expressed in Escherichia coli: assignment of the disulfide bridges of the purified unglycosylated protein. FEBS Lett. 283: 61-64, 1991.
19. Proudfoot, A. E. I., D. Fattah, E. H. Kawashima, A. Bernard, and P. T. Wingfield. Preparation and characterization of recombinant human IL-5 expressed in Escherichia coli. Biochem. J. 270: 357-361, 1990.
20. Takatsu, K., and A. Tominaga. Interleukin 5 and its receptors. Prog. Growth Factor Res. 3: 87-102, 1991.
21. Tavernier, J., R. Devos, J. Van Der Hayden, G. Haquier, R. Bauden, I. Fache, E. Kawashima, J. Vandekerckhove, R. Contreras, and W. Fiers. Expression of human and murine IL-5 in eukaryotic systems. DNA 8: 491-501, 1989.
22. Tsujimoto, M., H. Adachi, S. Kodama, N. Tsuroaka, Y. Yamada, S. Tanaka, S. Mita, and K. Takatsu. Purification and characterization of recombinant human IL-5 expressed in Chinese hamster ovary cells. J. Biochem. 106: 23-28, 1989.
23. Van Oosterhout, A. J. M., I. van Ark, G. Folkerts, H. J. van der Linde, H. F. J. Sarelkout, A. K. C. P. Verheyen, and F. P. Nijkamp. Antibody to IL-5 inhibits virus-induced airway hyperresponsiveness to histamine in guinea pigs. Am. J. Respir. Crit. Care Med. 131: 177-183, 1994.
24. Van Oosterhout, A. J. M., A. R. C. Ladenius, H. F. J. Savelkoul, I. van Ark, K. C. Delsman, and F. P. Nijkamp. Effect of anti-IL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea pigs. Am. Rev. Respir. Dis. 147: 548-552, 1993.
25. Van Regenmortel, M., J. Briand, S. Muller, and S. Plaue. In: Synthetic Peptides as Antigens, edited by R. H. Burdon and P. van Kippenberg. Amsterdam: Elsevier, 1988, Chapt. 6, p. 159-175.